Leishmania resistance to miltefosine associated with genetic marker

Emerg Infect Dis. 2012 Apr;18(4):704-6. doi: 10.3201/eid1804.110841.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Amphotericin B / pharmacology
  • Amphotericin B / therapeutic use
  • Antiprotozoal Agents / pharmacology*
  • Antiprotozoal Agents / therapeutic use
  • Drug Resistance*
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Leishmania donovani / drug effects*
  • Leishmaniasis, Visceral / diagnosis*
  • Leishmaniasis, Visceral / parasitology
  • Leishmaniasis, Visceral / prevention & control*
  • Maintenance Chemotherapy
  • Middle Aged
  • Phosphorylcholine / analogs & derivatives*
  • Phosphorylcholine / pharmacology
  • Phosphorylcholine / therapeutic use
  • Recurrence

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine
  • Amphotericin B